Pneumo- and cardiotoxic side effects following combination chemotherapy with epirubicin and ifosfamide
Franzen, D.; Pöhler, E.; Hilger, H.H.
Medizinische Klinik 85(Suppl 1): 133-136; 170
1990
ISSN/ISBN: 0723-5003 PMID: 2160577 Document Number: 365968
Document emailed within 1 workday
Related Documents
Chen, Y.M.; Perng, R.P.; Yang, K.Y.; Wu, H.W.; Lin, W.C.; Liu, J.M.; Tsai, C.M.; Whang-Peng, J. 2000: Combination chemotherapy with tamoxifen, ifosfamide, epirubicin and cisplatin in extensive-disease small-cell lung cancer Zhonghua Yi Xue Za Zhi 63(8): 605-611Zeymer, U.; Neuhaus, K.L. 1991: The cardiotoxic side effects of 5-fluorouracil Deutsche Medizinische Wochenschrift 116(5): 196-197
Sawada, M.; Inagaki, M.; Hirota, Y.; Hongo, J.; Ozaki, M. 1987: Ifosfamide, cisplatin, adriamycin combination chemotherapy in gynecologic cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(11): 3091-3094
Takeuchi, S.; Fukui, I.; Higashi, Y.; Andoh, M.; Kihara, K.; Kitahara, S.; Horiuchi, S.; Oshima, H. 1989: Combination chemotherapy with ifosfamide, 5-fluorouracil, cisplatin for stage D2 prostatic cancer Hinyokika Kiyo. Acta Urologica Japonica 35(9): 1513-1517
Hattori, Y.; Takizawa, A.; Kishida, T.; Kakizoe, M.; Fujikawa, N.; Teranishi, J.-I.; Kondo, K.; Saito, K.; Noguchi, K.; Nakaigawa, N.; Kubota, Y. 2007: Clinical study of combination chemotherapy of methotrexate, epirubicin and nedaplatin (MEN) in patients with advanced urothelial carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(5): 739-743
Kanamori, M.; Kumabe, T.; Saito, R.; Yamashita, Y.; Sonoda, Y.; Tominaga, T. 2010: The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases No Shinkei Geka. Neurological Surgery 38(11): 997-1005
Hoffman, P.C.; Masters, G.A.; Drinkard, L.C.; Krauss, S.A.; Samuels, B.L.; Golomb, H.M.; Vokes, E.E. 1996: Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies Seminars in Oncology 23(3 Suppl 6: 11-15
Brock, N.; Stekar, J.; Pohl, J.; Niemeyer, U.; Scheffler, G. 1979: Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide Arzneimittel-Forschung 29(4): 659-661
Halim, A.; Wahba, H. 2012: Cisplatin-ifosfamide combination chemotherapy in metastatic triple-negative, anthracycline- and taxane-pretreated breast cancer patients; a phase II study Journal of BUON: Official Journal of the Balkan Union of Oncology 17(2): 254-258
Unsal, M.; Erturk, D. 2003: Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer Saudi Medical Journal 24(6): 628-631
Li, X.-R.; Wang, J.-D.; Zhang, Y.-J.; Kong, Q.-L.; Ma, B.; Li, J.; Zheng, Y.-Q.; Chen, Y.-Q.; Jin, Y.-C.; Li, R. 2009: Effects of neoadjuvant chemotherapy of docetaxel combined with and epirubicin or pirarubicin on breast cancer: clinical analysis of 160 cases Zhonghua Yi Xue Za Zhi 89(2): 87-90
Katsuya, H.; Tamura, K. 2015: Side effects of chemotherapy Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 2): 39-44
Ghione, M. 1980: Side-effects of antitumor chemotherapy Minerva Medica 71(15): 1095-1099
Gendron, F.ço.; Bérubé, J.; Charbonneau, L.; Guilbert, E.; Leboeuf, M.; Ouellet, S.; Risi, C.; Roy, G.èv.; Steben, M.; Wagner, M.-S.; Lussier, S.; Martin, R.ée.-C. 2014: Irregular bleeding. Control of side effects of combination drugs Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 11(2): 34-35
Mandlekar, A.; Vaidya, P.; Motashaw, N.; Purandare, V.N. 1978: Oral contraceptives--acceptability and side effects with combination pills Journal of Obstetrics and Gynaecology of India 28(2): 296-300
Berg, D. 1998: Managing the side effects of chemotherapy for colorectal cancer Seminars in Oncology 25(5 Suppl 11: 53-59
Zhu, Q.-c.; Jin, Z.-m. 2011: Efficacy and side effects of combination therapy of oxaliplatin and S-1 for colorectal cancer Zhonghua Zhong Liu Za Zhi 33(5): 388-390
Bal'tseva, L.B.; Mel'nik, G.V.; Man'ko, V.P. 1990: The elimination of chemotherapy side effects in pulmonary tuberculosis patients Vrachebnoe Delo 4: 71-73
Noguchi, S.; Kubota, Y.; Shuin, T.; Masuda, M.; Misaki, H.; Yao, M.; Kondoh, K.; Sakuramoto, T.; Hosaka, M. 1994: M-VAC chemotherapy for advanced urothelial cancer--side effects and their management Hinyokika Kiyo. Acta Urologica Japonica 40(8): 677-682
Fushiki, H. 2004: Kampo therapy for side effects of gynecologic carcinomatous chemotherapy Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 10): 623-626